Osaic Holdings
COCP icon

Osaic Holdings’s Cocrystal Pharma COCP Stock Holding History

Osaic Holdings’s Portfolio COCP Stock Details COCP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-17
Closed -$29 – 7437
2024
Q3 		$29 Buy
+17
New +$33 ﹤0.01% 7325
2023
Q3 		– Sell
-2
Closed -$5 – 7417
2023
Q2 		$5 Hold
2
– – ﹤0.01% 7425
2023
Q1 		$4 Hold
2
– – ﹤0.01% 7472
2022
Q4 		$0 Hold
2
– – ﹤0.01% 7211
2022
Q3 		$0 Sell
2
-16
-89% -$75 ﹤0.01% 7287
2022
Q2 		$0 Hold
18
– – ﹤0.01% 7374
2022
Q1 		$0 Sell
18
-28
-61% -$186 ﹤0.01% 7274
2021
Q4 		$0 Sell
46
-513
-92% -$5.25K ﹤0.01% 7405
2021
Q3 		$6K Buy
559
+2
+0.4% +$26 ﹤0.01% 6436
2021
Q2 		$8K Hold
557
– – ﹤0.01% 6180
2021
Q1 		$9K Buy
557
+346
+164% +$7.03K ﹤0.01% 5918
2020
Q4 		$3K Buy
211
+167
+380% +$2.32K ﹤0.01% 5934
2020
Q3 		$0 Buy
+44
New +$803 ﹤0.01% 6232

Other funds holding COCP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Osaic Holdings's COCP Position: Q4 2024 in Review

Osaic Holdings sold out of Cocrystal Pharma (COCP) in Q4 2024, closing a stake of 17 shares — an estimated $29 sold.

Osaic Holdings first reported a position in COCP in Q3 2020 and held it in 13 quarters. The position peaked at $9K in Q1 2021. 24 funds tracked by Wall St. Rank hold COCP as of Q4 2024.

  • Osaic Holdings reported no remaining Cocrystal Pharma position as of Q4 2024 after selling out during the quarter.
  • Osaic Holdings sold 17 Cocrystal Pharma shares in Q4 2024, an estimated $29.
  • Osaic Holdings first reported a position in Cocrystal Pharma in Q3 2020 and held it in 13 quarters.
  • Osaic Holdings's Cocrystal Pharma position peaked at $9K in Q1 2021.
  • 24 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q4 2024.

Based on Osaic Holdings's 13F filing for Q4 2024, filed 7 Feb 2025.